Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, selectively induces growth suppression and cell death of endometrial stromal sarcoma cells in vitro

被引：0
|
作者：
Hrzenjak, Andelko [1 ]
Moinfar, Farid [1 ]
Kremser, Marie-Luise [1 ]
Strohmeier, Bettina [1 ]
Zatloukal, Kurt [1 ]
Denk, Helmut [1 ]
机构：
[1] Med Univ Graz, Dept Pathol, Graz, Austria
来源：
VIRCHOWS ARCHIV | 2007年 / 451卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：401 / 401
页数：1
相关论文
共 50 条
  • [21] Suberoylanilide Hydroxamic Acid, an Inhibitor of Histone Deacetylase, Induces Apoptosis in Rheumatoid Arthritis Fibroblast-Like Synoviocytes
    Hui Chen
    Jing Pan
    Jin-dan Wang
    Qiu-mei Liao
    Xiao-ru Xia
    Inflammation, 2016, 39 : 39 - 46
  • [22] Histone deacetylase inhibitor suberoylanilide hydroxamic acid targets breast cancer stem cells and inhibits metastasis
    Chu, K.
    Green, T. L.
    Boley, K. M.
    Cristofanilli, M.
    Robertson, F. M.
    CANCER RESEARCH, 2013, 73
  • [23] Inhibition of oral carcinogenesis in rats by the histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA)
    McCormick, David L.
    Horn, Thomas L.
    Johnson, William D.
    Lubet, Ronald A.
    Steele, Vernon E.
    CANCER RESEARCH, 2011, 71
  • [24] Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, improved radiosensitivity of human hepatocellular carcinoma
    Chen, Fang-Hsin
    Yu, Ching-Fang
    Hong, Ji-Hong
    CANCER RESEARCH, 2017, 77
  • [25] The histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces cardiac arrhythmias in dystrophic mice
    Colussi, Claudia
    Berni, Roberta
    Rosati, Jessica
    Straino, Stefania
    Vitale, Serena
    Spallotta, Francesco
    Baruffi, Silvana
    Bocchi, Leonardo
    Delucchi, Francesca
    Rossi, Stefano
    Savi, Monia
    Rotili, Dante
    Quaini, Federico
    Macchi, Emilio
    Stilli, Donatella
    Musso, Ezio
    Mai, Antonello
    Gaetano, Carlo
    Capogrossi, Maurizio C.
    CARDIOVASCULAR RESEARCH, 2010, 87 (01) : 73 - 82
  • [26] The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells
    Hsi, LC
    Xi, XP
    Lotan, R
    Shureiqi, I
    Lippman, SM
    CANCER RESEARCH, 2004, 64 (23) : 8778 - 8781
  • [27] Suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor, suppresses the growth of carcinogen-induced mammary tumors
    Cohen, LA
    Marks, PA
    Rifkind, RA
    Amin, S
    Desai, D
    Pittman, B
    Richon, VM
    ANTICANCER RESEARCH, 2002, 22 (03) : 1497 - 1504
  • [28] Suberoylanilide Hydroxamic Acid, a Histone Deacetylase Inhibitor, Induces the Production of Anti-inflammatory Cyclodepsipeptides from Beauveria felina
    Chung, Yu-Ming
    El-Shazly, Mohamed
    Chuang, Da-Wei
    Hwang, Tsong-Long
    Asai, Teigo
    Oshima, Yoshiteru
    Ashour, Mohamed L.
    Wu, Yang-Chang
    Chang, Fang-Rong
    JOURNAL OF NATURAL PRODUCTS, 2013, 76 (07): : 1260 - 1266
  • [29] The histone deacetylase inhibitor, suberoylanilide hydroxyamic acid, induces apoptosis of multiple myeloma cells.
    Feinman, R
    Gangurde, P
    Barton, BE
    Abungu, B
    Rivera, C
    Richon, VM
    Siegel, DS
    BLOOD, 2002, 100 (11) : 809A - 809A
  • [30] The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species
    Ruefli, AA
    Ausserlechner, MJ
    Bernhard, D
    Sutton, VR
    Tainton, KM
    Kofler, R
    Smyth, MJ
    Johnstone, RW
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (19) : 10833 - 10838
12345